Can-Fite BioPharma Ltd. Increase Decrease In Cash And Cash Equivalents
Can-Fite BioPharma Ltd. (CANF) reported Increase Decrease In Cash And Cash Equivalents of -$918.00 thousand for the 12-month period ending 2019-12-31, per its 20-F filed 2020-03-27.
Discontinued › Cash Flow › Operating Activities
ifrs-full:IncreaseDecreaseInCashAndCashEquivalents · last filed 2020-03-27
| Period end | Increase Decrease In Cash And Cash Equivalents 6 month | Increase Decrease In Cash And Cash Equivalents 12 month | Increase Decrease In Cash And Cash Equivalents 12 month as first filed |
|---|---|---|---|
| 2019-12-31 | -$918.00K 20-F · filed 2020-03-27 | ||
| 2019-06-30 | $4.59M 6-K · filed 2019-08-30 | ||
| 2018-12-31 | $110.00K 20-F · filed 2020-03-27 | ||
| 2018-06-30 | $2.33M 6-K · filed 2019-08-30 | ||
| 2017-12-31 | -$4.61M 20-F · filed 2020-03-27 | -$5.49M 20-F · filed 2018-03-28 | |
| 2017-06-30 | -$1.25M 6-K · filed 2018-08-31 | ||
| 2016-12-31 | -$8.81M 20-F · filed 2019-03-29 | ||
| 2015-12-31 | $7.64M 6-K · filed 2018-08-08 |